Strip two items out of the quarter that made Petco Health and Wellness look like a turnaround, and the company earned less money than it did a year earlier.
That is not the story the tape has been telling. Petco runs 1,377 pet care centers across the United States and Puerto Rico, with roughly 300 wholly-owned veterinary hospitals built inside them, and holds half of a joint venture that operates about 150 more stores in Mexico and two in Chile . It reports as one segment and splits its revenue three ways: consumables, about half the business and the category that drives trips; supplies and companion animals, a third; and services and other — veterinary care, grooming, training — the remaining 18% . Shares trade at ~$3.12 intraday on November 9, roughly 46% above the $2.14 low of the past year and about 17% below the $3.78 high .
The evidence behind that rally is the September 2 print, and the shares have climbed to current levels without a quarterly report since. Petco delivered its second consecutive quarter of positive comparable sales, operating income up 11.1% to $47.8 million, Adjusted EBITDA of $122.2 million against $113.9 million a year earlier, and a voluntary $75 million debt prepayment announced alongside it, with the full-year outlook reaffirmed . Read against a company that spent fiscal 2023 writing off more than a billion dollars of carrying value, that is a credible turn. My argument is that the turn is real and is happening almost entirely in the capital structure rather than in the store, that the market has already paid for the part that has been demonstrated, and that the operating lever most capable of justifying a higher multiple moved the wrong way in the quarter investors cheered.
The profit improvement was a tariff refund and a Mexican affiliate
Petco's Adjusted EBITDA is not a consolidated number. The reconciliation adds in 50% of the Mexico joint venture's EBITDA — $13.1 million in the quarter against $10.4 million a year earlier — even though that stake is an equity-method investment reported net of its own depreciation and taxes, so none of it arrives as consolidated cash . The quarter also carried a net $6.8 million benefit from refunds of tariffs previously paid under the International Emergency Economic Powers Act, money the company received once and has told investors not to expect again this year .
Take both out and the picture inverts: consolidated Adjusted EBITDA of roughly $102.3 million against $103.5 million on the same basis a year earlier, a decline of about 1.2%. The two items together more than account for the reported improvement. Management's own normalized figure — $115.4 million, excluding the refund but still including Mexico — was above both the prior year and its outlook , and that is fair as far as it goes. It simply does not describe the US store business, which is what the equity owns.
The rest of the improvement down to net income is similarly composed. The quarter booked a $15.7 million income tax benefit, driven by a $13.4 million release of unrecognized tax benefits after the Joint Committee on Taxation completed a federal refund review . First-half free cash flow of $60.8 million against $9.9 million a year earlier is a genuine improvement, but a $5.1 million payables inflow replaced a $69.7 million outflow in the prior-year half — a roughly $75 million swing that is working capital, not earnings. None of this is improper, and all of it is disclosed. Added together, it makes a flat business look like it inflected.
Services, the only growing line, halved its growth rate
The category detail is where the thesis has to be tested. Consumables rose 0.2% to $731.3 million, supplies and companion animals fell 2.0% to $485.6 million, and services and other grew 3.6% to $272.4 million . Getting consumables to positive is a real marker — it is the traffic category, and it had been shrinking. But services is the line that carries the model, because products are flat and services supply most of the incremental gross-profit dollars available to fund operating leverage.
Services grew 5.2% across the first half. Since the second quarter contributed $272.4 million of that $541.0 million, the first quarter must have run at about 6.8% ($268.6 million against $251.5 million) — which is to say growth halved in a single quarter. The explanation offered is the national relaunch of Petco Perks, the customer membership program, which made point redemption dramatically easier and produced redemption volumes far above projection; the CFO sized the sales impact at mid-single-digit millions, and the company says guardrails are now in place with peak redemptions behind it .
I lean toward accepting that framing, with one reservation that matters. The timing fits a launch spike: the drag concentrated in the single quarter following the national rollout, and it hit services hardest while consumables — the category a disengaging customer would abandon first — improved. What the framing does not establish is that redemption is a one-time cost rather than a permanent toll on a program the company intends to run indefinitely. Management expects the personalization payoff to emerge in 2027 , which is to say not this year. The third-quarter report, expected late this month, is the clean read: services back near 6% would validate the spike; services stuck in the mid-3s would say the relaunch repriced the loyalty base.
Three hundred owned vet hospitals are the asset worth arguing about
The strongest operating asset here is the hospital fleet. Roughly 300 full-service veterinary hospitals sit inside existing pet care centers, every veterinarian a Petco employee, with total pet visits growing double digits and doctor days expanded double digits to meet that demand — in a market where management says adoptions are down industry-wide . Licensed veterinary capacity attached to retail square footage is a genuinely awkward thing for a subscription e-commerce rival to replicate, and it is the main reason this is not simply a melting ice cube.
It is also, for now, a maturation story rather than a growth story. The CFO's framing is that the existing 300 have a healthy runway of return improvement available without adding capital, mostly by matching veterinarian labor supply to demand ; new hospital openings begin in 2027 and have not been sized . Petco has stopped reporting hospital economics separately, on the argument that a hospital's value shows up in the whole store . That is defensible operationally and unhelpful analytically: the 2027 opening program will be the first real test of incremental return on new capital under this management team, and outside investors will not be able to measure it directly.
The deleveraging is real, and the sponsor controls the timing
The strongest part of the story overall is the balance sheet. Total debt stood at $1.48 billion at August 1 against $1.19 billion of net debt, with a $293.5 million cash balance , and the company has prepaid $170 million over nine months, taking net leverage from 4.2x to 2.8x on management's measure . The reaffirmed fiscal 2026 outlook calls for $415–430 million of Adjusted EBITDA, about $140 million of capex against roughly $200 million of depreciation, and net interest cut to about $122 million on the back of the prepayment . At 2x, management has said it would begin discussing shareholder distributions .
Two things complicate that. First, the 2.8x is flattered by the same JV add-in: against the roughly $371 million of fiscal 2026 Adjusted EBITDA that excludes Mexico, net debt is closer to 3.2x. Second, Petco is a controlled company. Funds advised by CVC Capital Partners together with Canada Pension Plan Investment Board controlled about 51.2% of voting power through their principal stockholder as of the May 2026 proxy, and the stockholder's agreement requires that entity's prior written consent before the company takes certain significant actions . The sponsors own common equity, so their economics broadly align with other holders; what they control is timing. When the cash currently going to lenders starts going to shareholders, and in what form, is not a decision the minority gets to make.
With net debt at roughly 57% of enterprise value, debt paydown is nonetheless where equity value actually accretes. Around $135 million of free cash flow over the next five quarters, on management's definition of operating cash flow less capex, is worth about $0.47 a share across 286 million Class A and B-1 shares. That is meaningful against a $3 stock. It is also the slowest way to create equity value that a leveraged retailer has.
At 7x EBITDA less capex, the recovery is already in the price
Enterprise value is about $2.08 billion: 286.0 million Class A and Class B-1 shares at ~$3.12 , plus the August 1 net debt (the September prepayment used cash, so it barely moves the net figure) . Against my estimate of roughly $439 million of Adjusted EBITDA over the next twelve months that is 4.7x — and 4.7x looks like deep value until you remember that about $54 million of it belongs to an unconsolidated Mexican affiliate and that keeping 1,377 stores and 300 hospitals competitive costs real money.
Take capex out, at the roughly $155 million the next twelve months should carry once 2027 hospital openings and remodels are layered onto this year's $140 million run rate, and the multiple is 7.3x EBITDA less capex. That is the basis on which this business should be judged, and on it the past year's trading range maps to roughly 6.3x at the low and 8.0x at the high against the same net debt — so the stock already sits in the upper half of its own range after a quarter in which consolidated earnings went backwards. On trailing EV/EBITDA as of November 9 the gap to the sector's growth asset is wide and largely deserved: Petco near 5.8x against Chewy at 18.8x , on a vendor-standard trailing basis that excludes Petco's JV add-back, for a company compounding sales at about 1% against one still growing mid-single digits with no net leverage to speak of.
My base case is $3.18 a year out — 7.0x forward EBITDA less capex of $284 million, less about $1.05 billion of forward net debt, across 295 million diluted shares — which is effectively spot, with debt paydown supplying all of the equity growth. Getting to roughly 8.0x, the top of the past year's range, requires services re-accelerating above 6% and fiscal 2027 Adjusted EBITDA near $470 million; that combination is worth about $4.94 a share. It is a case the most recent quarter argued against rather than for.
What breaks it: a flat store base carrying $1.5 billion of debt and $1.35 billion of leases
The bear case does not require a recession. Supplies and companion animals has fallen from $2.21 billion in the fiscal year ended February 2024 to $1.97 billion in the year ended January 2026, down about 11%, while consumables slipped roughly 3% over the same span . Petco's own risk disclosure names one mechanism directly: premium food brands that specialty retail once had to itself becoming widely available through supermarkets and mass merchants . That is a structural channel migration, and nothing in the past four quarters shows it reversing — flat consumables is the absence of further loss, not growth.
Underneath a thin equity layer sits $1.5 billion of funded debt and $1.35 billion of operating lease liabilities . Rent is charged above EBITDA, inside SG&A, which is why an EBITDA multiple quietly ignores that second obligation even though it is fixed and senior to the equity in substance. Capex at about 70% of depreciation keeps near-term free cash flow above its sustainable level; the 2027 program of hospital openings and store remodels, neither of which has been quantified, is exactly the kind of commitment that closes that gap. Goodwill and trade name together carry $2.0 billion against $1.21 billion of book equity and roughly $892 million of market value — an annual impairment test run with the market below book is not a cash event, but it is a reminder of what the public market thinks those assets are worth. And the CEO's own read on the customer, offered in September, was that the consumer is under a lot of stress, with guidance assuming neither improvement nor deterioration . Fiscal 2027 Adjusted EBITDA of $418 million — barely below this year's guided range — on a 6.0x multiple of EBITDA less capex, against about $1.12 billion of net debt, produces $1.40 a share. The downside is less probable than the base case, but it is comparable in size to the upside, which is what 57% leverage does to a thin equity layer.
Credit repair, priced as an equity recovery
Petco is executing. Seven consecutive quarters of hitting its own profitability and cash-flow marks, inventory down 1% on top of a 9.5% decline the prior year , SG&A held roughly flat, $170 million of debt retired — this is a management team doing the controllable things well, and lenders have been the clear beneficiaries. The equity has already been paid for that work: at 7.3x forward EBITDA less capex and in the upper half of its trading range, the stock discounts a deleveraging path that is largely in hand and a services recovery that has not yet shown up in a reported quarter. Those are the wrong odds to take. The market is pricing Petco's improving credit as though it were an improving business; until the third-quarter services line says otherwise, this is a fairly valued equity with the skew leaning down.
This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any security. It reflects the analysis and opinions of the author as of the date of publication and may not be updated. Do your own research and consult a licensed financial advisor before making investment decisions.